Peter Maag - Feb 7, 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Ankur Dhingra, as attorney-in-fact for Peter Maag
Stock symbol
CDNA
Transactions as of
Feb 7, 2022
Transactions value $
-$420,668
Form type
4
Date filed
2/8/2022, 08:58 PM
Previous filing
Feb 4, 2022
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Sale -$205K -4.9K -1.5% $41.80 323K Feb 7, 2022 Direct F1, F2
transaction CDNA Common Stock Sale -$216K -5.1K -1.58% $42.32 318K Feb 7, 2022 Direct F1, F3
holding CDNA Common Stock 1K Feb 7, 2022 As UTMA custodian for minor child F4
holding CDNA Common Stock 1K Feb 7, 2022 As UTMA custodian for minor child F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.085 to $42.080, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.095 to $42.635, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.